EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis

Camila Aparicio iD, Zachary I Willis iD, Mari M Nakamura iD, Joshua Wolf iD, Cordell Little, Gabriela M Maron, Paul K Sue, Brenda I Anosike, Christine Miller iD, Laura L Bio iD, Prachi Singh, Scott H James und 1 weitere

Journal of the Pediatric Infectious Diseases Society · 20.07.2024 · 13 (7) · 352-362

DOI: 10.1093/jpids/piae052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 23.05.2024. Verfasst von Camila Aparicio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Comorbidity, COVID-19, Critical Illness. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society COVID-19 treatment guidance. This systematic review and meta-analysis aimed to define the clinical characteristics and comorbidities associated with critical COVID-19 in children and adolescents.

Methods

Two independent reviewers screened the literature (Medline and EMBASE) for studies published through August 31, 2023, that reported outcome data on patients aged ≤21 years with COVID-19. Critical disease was defined as an invasive mechanical ventilation requirement, intensive care unit admission, or death. Random-effects models were used to estimate pooled odds ratios (OR) with 95% confidence intervals (CI), and heterogeneity was explored through subgroup analyses.

Results

Among 10,178 articles, 136 studies met the inclusion criteria for review. Data from 70 studies, which collectively examined 172,165 children and adolescents with COVID-19, were pooled for meta-analysis. In previously healthy children, the absolute risk of critical disease from COVID-19 was 4% (95% CI, 1%–10%). Compared with no comorbidities, the pooled OR for critical disease was 3.95 (95% CI, 2.78–5.63) for the presence of one comorbidity and 9.51 (95% CI, 5.62–16.06) for ≥2 comorbidities. Key risk factors included cardiovascular and neurological disorders, chronic pulmonary conditions (excluding asthma), diabetes, obesity, and immunocompromise, all with statistically significant ORs > 2.00.

Conclusions

While the absolute risk for critical COVID-19 in children and adolescents without underlying health conditions is relatively low, the presence of one or more comorbidities was associated with markedly increased risk. These findings support the importance of risk stratification in tailoring pediatric COVID-19 management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ComorbidityCOVID-19Critical IllnessAdolescentChildChild, PreschoolHumansInfantRespiration, ArtificialRisk FactorsSARS-CoV-2Young Adult

Stichwörter der Autor:innen

COVID-19comorbiditiespediatricpredictors of severityrisk factors

Autor:innen und Institutionen

  • Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Antimicrobial Stewardship Program and Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Infectious Diseases, St. Jude Children's Research Hospital and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Pediatrics, The Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Camila Aparicio, Zachary I Willis, Mari M Nakamura, Joshua Wolf, Christine Miller, Laura L Bio, Carlos R Oliveira

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIH

Zitieren

APA

Aparicio, C., Willis, Z. I., Nakamura, M. M., Wolf, J., Little, C., Maron, G. M., Sue, P. K., Anosike, B. I., Miller, C., Bio, L. L., Singh, P., James, S. H., & Oliveira, C. R. (2024). Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis. Journal of the Pediatric Infectious Diseases Society, 13(7), 352-362. https://doi.org/10.1093/jpids/piae052

Vancouver

Aparicio C, Willis ZI, Nakamura MM, Wolf J, Little C, Maron GM, et al. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis. Journal of the Pediatric Infectious Diseases Society. 2024;13(7):352-362. doi:10.1093/jpids/piae052

BibTeX
@article{Aparicio2024,
  author = {Aparicio, Camila and Willis, Zachary I and Nakamura, Mari M and Wolf, Joshua and Little, Cordell and Maron, Gabriela M and Sue, Paul K and Anosike, Brenda I and Miller, Christine and Bio, Laura L and Singh, Prachi and James, Scott H and Oliveira, Carlos R},
  title = {Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  volume = {13},
  number = {7},
  pages = {352--362},
  doi = {10.1093/jpids/piae052}
}
Kostenlos starten →